|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Biotechnology in the Netherlands |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Septembre 2005 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 52 pages | Mars 2001 | Anglais
|
|
|
| Main
focus: |
biotechnology,bioinformatics,bio informatics,...,...
|
| Research
focus: |
market size and estimates,market segmentation, |
| Geographic
focus: |
canada,united kingdom,usa,france |
| |
|
|
|
|
| 271 pages | Juillet 2006 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,biotech crops,bioinformatic,...,...
|
| Research
focus: |
competition analysis,market size and estimates, |
| Geographic
focus: |
france,united kingdom,hungary,czech republic,... |
| |
|
|
|
|
| 90 pages | Janvier 1998 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,genetics,drug discovery,...
|
| Research
focus: |
competition analysis,market outlook, |
| Geographic
focus: |
usa,india,uruguay,chile,colombia,venezuela,... |
| |
|
|
|
|
| 44 pages | Juin 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
france,germany,united kingdom,japan,spain,... |
| |
|
|
|
|
| 44 pages | Janvier 2001 | Anglais
|
|
|
| Main
focus: |
biotechnology,biotech,biotechnology patents,...,...
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,switzerland,united kingdom,germany,france |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
03-052B: The DNA Purification Market: Keys to Success for Commercial Kit Suppliers 152 pages | Octobre 2003 |
This report is designed to help life science product managers understand customers in the DNA purification market and the factors that drive their purchasing behavior |
1 280,00 €
|
| |
| |
Biochips 150 pages | Décembre 2000 |
The notion of a cheap and reliable computer chip look-alike that performs thousands of biological reactions is a very attractive one, because it miniaturizes, automates and accelerates otherwise cumbe |
1 400,00 €
|
| |
| |
03-026: The Market for Tissue Microarrays 134 pages | Juillet 2003 |
This report provides vital information on end-users’ scientific objectives, instrumentation for production and analysis of TMAs, outsourcing practices and preferred TMA suppliers |
640,00 €
|
| |
| |
03-054: Immunohistochemistry Market Benchmarking Survey 90 pages | Octobre 2003 |
This report provides an overview of the most commonly used methods and products for tissue/sample preparation and antigen detection to help suppliers understand researchers’ experiences, preferences a |
680,00 €
|
| |
| |
03-010: The Market for Toxicogenomics Products & Services 193 pages | Avril 2003 |
This report provides a look at service providers, informatics products, microarrays and databases from the end-user's perspective |
640,00 €
|
| |
| |
The Pharmacogenomics Outlook 174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development. By identifying differenc |
955,00 €
|
| |
| |
The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets 150 pages | Janvier 2002 |
Genomics is quietly transforming the pharmaceutical industry. Companies are moving from medicinal chemistry based drug discovery and development, to using information provided by genomics. V |
953,48 €
|
| |
| |
Carbohydrate Therapeutics IRCD pages | Juillet 2001 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ |
1 200,00 €
|
| |
| |
Pharmacogenomics 160 pages | Décembre 2000 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which |
1 400,00 €
|
| |
| |
Genomic Revolution: Trends & Opportunities 30 pages | Octobre 2002 |
Computational advancements in Genomic technology have brought a revolution in the field of application of Pharmaco-Therapy. Companies are diversifying their business prospect from medical chemistry |
600,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Biotechnology in the Netherlands |
|
|
Datamonitor's Biotechnology in the Netherlands industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope * Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2004 annual average exchange rates.
For the purposes of this report, Europe consists of Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, Bulgaria, Czech Republic, Hungary, Poland, Romania, Russia, Slovakia and the Ukraine.
Asia-Pacific consists of China, Hong Kong, India, Japan, Malaysia, Singapore, South Korea, Vietnam, Australia and New Zealand.
The global market is composed of Europe, Asia-Pacific, US, Canada, Turkey, Argentina, Brazil, Chile, Colombia, Mexico, Algeria, Egypt, Israel, UAE, Saudi Arabia and South Africa.
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Competitive Landscape 12
CHAPTER 6 Leading Companies 13
6.1 Diosynth 13
6.2 DSM N.V. 13
6.3 Genzyme Corporation 14
6.4 Qiagen N.V. 14
6.5 Solvay Group 14
CHAPTER 7 Market Forecasts 15
7.1 Market Value Forecast 15
CHAPTER 8 Macroeconomic Indicators 16
CHAPTER 9 Further Reading 18
9.1 Sources 18
9.2 Related Datamonitor Research 18
LIST OF TABLES
Table 1: Netherlands Biotechnology Market Value: $ million, 2000-2004 9
Table 2: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2004 10
Table 3: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2004 11
Table 4: Netherlands Biotechnology Market Value Forecast: $ million, 2004-2009 15
Table 5: Netherlands Size of Population (million) , 2000-2004 16
Table 6: Netherlands GDP (1995=100), 2000-2004 16
Table 7: Netherlands Inflation, 2000-2004 16
Table 8: Netherlands Exchange Rate, 2000 17
CONTENTS
|
|
|
PPLSEN
|
|
|
|
|